Patients with comorbid autoimmune bullous disease and acquired hemophilia A who were of older age were significantly associated with mortality.

Researchers from the Centenary Institute have uncovered a reason why some people with hemophilia A develop resistance to ...

Cell and gene therapies harbor great hopes for biomedicine. They are becoming increasingly important for diseases that are ...

VIJAYAWADA: The State government is committed to ensuring uninterrupted care for citizens with rare and chronic disorders like hemophilia, Health Minister Y Satya Kumar Yadav said while ...

Hemophilia A disrupts this vital process by specifically affecting Factor VIII (8), a crucial component in the clotting sequence. Without sufficient quantities of functioning Factor VIII ...

Jivi antihemophilic factor is now approved for children aged 7-12 with hemophilia A, expanding its previous approval for older patients. Hemophilia A is more common than hemophilia B, with early ...

In the spring of 2024, the US Food and Drug Administration (FDA) approved fidanacogene elaparvovec (Beqvez), only the second gene therapy product for hemophilia B. Just a few months later ...

Hemophilia is a rare genetic condition that prevents your blood from clotting and can lead to bleeding problems. People with hemophilia can have bleeding episodes that happen without trauma and ...

The enigmatic English masked metal outfit, comprising members Vessell and II, previously saw Albums Chart success with 2021’s This Place Will Become Your Tomb and 2023 LP Take Me Back To Eden (3).

It comes as the record’s title track Even In Arcadia eyes a Top 40 debut on this week’s Official Singles Chart (17); potentially earning the group a fourth UK Top 40 appearance in less than ...

The approval is based on data from the Alfa-PROTECT and PROTECT Kids studies, demonstrating Jivi’s safety and efficacy in children aged 7 to under 12 years with severe hemophilia A. This ...